Metabolic Control Analysis in a Cellular Model of Elevated MAO-B: Relevance to Parkinson’s Disease

被引:0
|
作者
Jyothi K. Mallajosyula
Shankar J. Chinta
Subramanian Rajagopalan
David G. Nicholls
Julie K. Andersen
机构
[1] Buck Institute for Age Research,
来源
Neurotoxicity Research | 2009年 / 16卷
关键词
Mitochondrial dysfunction; Monoamine oxidase B; Hydrogen peroxide; Krebs cycle enzymes; Metabolic control analysis; Reactive oxygen species;
D O I
暂无
中图分类号
学科分类号
摘要
We previously demonstrated that spare respiratory capacity of the TCA cycle enzyme alpha-ketoglutarate dehydrogenase (KGDH) was completely abolished upon increasing levels of MAO-B activity in a dopaminergic cell model system (Kumar et al., J Biol Chem 278:46432–46439, 2003). MAO-B mediated increases in H2O2 also appeared to result in direct oxidative inhibition of both mitochondrial complex I and aconitase. In order to elucidate the contribution that each of these components exerts over metabolic respiratory control as well as the impact of MAO-B elevation on their spare respiratory capacities, we performed metabolic respiratory control analysis. In addition to KGDH, we assessed the activities and substrate-mediated respiration of complex I, pyruvate dehydrogenase (PDH), succinate dehydrogenase (SDH), and mitochondrial aconitase in the absence and presence of complex-specific inhibitors in specific and mixed substrate conditions in mitochondria from our MAO-B elevated cells versus controls. Data from this study indicates that Complex I and KGDH are the most sensitive to inhibition by MAO-B mediated H2O2 generation, and could be instrumental in determining the fate of mitochondrial metabolism in this cellular PD model system.
引用
收藏
页码:186 / 193
页数:7
相关论文
共 50 条
  • [1] Metabolic Control Analysis in a Cellular Model of Elevated MAO-B: Relevance to Parkinson's Disease
    Mallajosyula, Jyothi K.
    Chinta, Shankar J.
    Rajagopalan, Subramanian
    Nicholls, David G.
    Andersen, Julie K.
    NEUROTOXICITY RESEARCH, 2009, 16 (03) : 186 - 193
  • [2] A critical appraisal of MAO-B inhibitors in the treatment of Parkinson's disease
    Jost, Wolfgang H.
    JOURNAL OF NEURAL TRANSMISSION, 2022, 129 (5-6) : 723 - 736
  • [3] Dietary Natural Flavonoids: Intervention for MAO-B Against Parkinson's Disease
    Singh, Ashini
    Sinha, Suman
    Singh, Niraj Kumar
    CHEMICAL BIOLOGY & DRUG DESIGN, 2024, 104 (03)
  • [4] Clinical benefit of MAO-B and COMT inhibition in Parkinson's disease: practical considerations
    Regensburger, Martin
    Ip, Chi Wang
    Kohl, Zacharias
    Schrader, Christoph
    Urban, Peter P.
    Kassubek, Jan
    Jost, Wolfgang H.
    JOURNAL OF NEURAL TRANSMISSION, 2023, 130 (06) : 847 - 861
  • [5] Inhibitors of MAO-B and COMT: their effects on brain dopamine levels and uses in Parkinson's disease
    Finberg, John P. M.
    JOURNAL OF NEURAL TRANSMISSION, 2019, 126 (04) : 433 - 448
  • [6] MAO-B and COMT Genetic Variations Associated With Levodopa Treatment Response in Patients With Parkinson's Disease
    Sampaio, Tiago Furtado
    Damasceno dos Santos, Erinaldo Ubirajara
    Cordeiro de Lima, Gessica Dayane
    Gueiros dos Anjos, Rute Salgues
    da Silva, Ronaldo Celerino
    Asano, Amdore Guescel C.
    Jorge Asano, Nadja Maria
    Crovella, Sergio
    Eleuterio de Souza, Paulo Roberto
    JOURNAL OF CLINICAL PHARMACOLOGY, 2018, 58 (07) : 920 - 926
  • [7] 2,6-Diarylbenzo[d]oxazoles as MAO-B inhibitors for the treatment of Parkinson's disease
    Lee, Haeun
    Sawant, Vikram Shahaji
    Kim, Uhyeok
    Kim, Jinhyeok
    Baek, Soo Yeon
    Lee, Sanghee
    Choo, Hyunah
    Kang, Taek
    Jeon, Byungsun
    BULLETIN OF THE KOREAN CHEMICAL SOCIETY, 2025,
  • [8] Pharmacological aspects of the neuroprotective effects of irreversible MAO-B inhibitors, selegiline and rasagiline, in Parkinson's disease
    Szoeko, Eva
    Tabi, Tamas
    Riederer, Peter
    Vecsei, Laszlo
    Magyar, Kalman
    JOURNAL OF NEURAL TRANSMISSION, 2018, 125 (11) : 1735 - 1749
  • [9] An inducible MAO-B mouse model of Parkinson's disease: a tool towards better understanding basic disease mechanisms and developing novel therapeutics
    Chamoli, Manish
    Chinta, Shankar J.
    Andersen, Julie K.
    JOURNAL OF NEURAL TRANSMISSION, 2018, 125 (11) : 1651 - 1658
  • [10] An inducible MAO-B mouse model of Parkinson’s disease: a tool towards better understanding basic disease mechanisms and developing novel therapeutics
    Manish Chamoli
    Shankar J. Chinta
    Julie K. Andersen
    Journal of Neural Transmission, 2018, 125 : 1651 - 1658